Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated Suspension

This study has been terminated.

( Difficulty finding the required subject population )

Study NCT00637403 Information provided by Par Pharmaceutical, Inc.

First Received on March 11, 2008. Last Updated on March 17, 2008 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Healthy

Additional conditions recognized in this trial

Renal Insufficiency

More general conditions related to this trial

Kidney Diseases
Urologic Diseases

Additional drug interventions recognized in this trial

Megestrol
Megestrol Acetate

More general drug interventions related to this trial

Sponsors listed in this trial

Par Pharmaceutical, Inc.
Covance
SFBC Anapharm